ArticleOncotarget2016
Multiple-level validation identifies PARK2 in the development of lung cancer and chronic obstructive pulmonary disease.
SeungBaek Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this papercites it